-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
IGM Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q3 2024.
- IGM Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.96M, a 41% decline year-over-year.
- IGM Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $15.1M, a 9.72% decline year-over-year.
- IGM Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $17.7M, a 159% increase from 2022.
- IGM Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $6.85M, a 4211% increase from 2021.
- IGM Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $159K, a 91.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)